The CDKN2A methylation rate was determined to be 79.6% in NSCLC tissues by MS-UC-FRET, 30.6% by RQ-PCR and 36.7%% by pyrosequencing in this study. The gene discussed is CDKN2A; the disease is non-small cell lung carcinoma.